Rheum officinale vs no treatment: ESKD
Rheum officinale showed no clear difference in incidence of ESKD Analysis method, calculated by regression… compared with no treatment (low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Rheum officinale vs no treatment Incidence of ESKD Analysis method, calculated by regression analysis: 1/SCr versus time. · Patients with chronic kidney disease Rheum officinale showed no clear difference in incidence of ESKD Analysis method, calculated by regression… compared with no treatment (low certainty). Rheum officinale (a traditional Chinese medicine) for chronic kidney disease (2012) · Cochrane Headline outcomes only | RR 0.53 [0.28, 1] | 2 studies · 124 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Rheum officinale (a traditional Chinese medicine) for chronic kidney disease 2012 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.